Welcome to
On Feet Nation
Thomas Shaw Online
Robinjack Online
Donna Online
Market Highlights:
Monoclonal antibody therapy market information, by source (recombinant, chimeric, humanized, human, and other), by application (diagnostic test, analytical and chemical uses, cancer treatment, autoimmune diseases, hematological disorders, and others) by end users (hospitals, clinic, research laboratories and others) - Forecast to 2027
The global monoclonal antibody therapy market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly in the near future. Antibodies are an important part of the immune system. Generally, our body creates antibodies in response to an antigen entering the body. These antibodies attach to the antigen in order to mark it as harmful which is then destroyed by the body's immune system. Monoclonal Antibodies are the antibodies produced in the laboratory which can mimic the function of a normal antibody to attack the antigen. However, monoclonal antibodies are engineered in such a way that they identify and attach to the mono-specific targeted antigen on the surface of the cancer cell or any other foreign cell. It is often referred to as a targeted immunotherapy. Monoclonal antibodies identify and destroy the tumor cells without causing any harm to the normal healthy cells of the body. The major application of the monoclonal antibody therapy is the treatment of the cancer. Having said that, Monoclonal antibody therapy can only be done for the cancers in which the antigens have been identified so far. Some of the common monoclonal antibodies are Alemtuzumab, Rituximab, Trastuzumab, Gemtuzumab ozogamicin, Ibritumomab Tioxetan.
The global market for monoclonal antibody therapy is growing continuously and expected to reach USD ~140 Billion by the end of 2022.
According to WHO, the world will witness more than 70% rise in the number of cancer patients in the next few years, out of which maximum number of patients will be from the Asia, Africa and South America region. There has been extensive research going on to develop the new monoclonal antibodies and drugs in order to treat the wide range of disorders with minimum side effects. The sudden rise in the number of cancer cases is likely to propel the growth of the monoclonal antibody therapy market in the near future. Moreover the commercialization of the newly developed monoclonal antibodies and drugs will give a boost to the monoclonal antibody therapy market. On the other hand, lack of awareness about the technology in the developing nations and the limited healthcare expenditure and low affordability of such expensive treatments in the low income economies is expected to hamper the growth of the monoclonal antibody market.
Global Monoclonal Antibody Therapy Market Players:
There are plenty of large and small market players which operate in this market all over the globe. The major participants of this market are AbbVie Inc., Amgen Inc., Bayer AG, Biogen Inc., Bristol–Myers Squibb Company, F. Hoffmann-La Roche Ltd., GenScript, GlaxoSmithKline Plc., Johnson Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Sigma-Aldrich Co. LLC, and others.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2089
Regional Analysis:
Depending on geographic region, monoclonal antibody therapy market is segmented into four key regions: America, Europe, Asia-Pacific, and Middle East Africa. Globally, America is the largest market for monoclonal antibody therapy. North American region is the leading market in the America region. Europe is the second-largest market globally for monoclonal antibody therapy which is expected to continue its growth in the near future. Asia pacific region is expected to be fastest growing region in monoclonal antibody therapy market.
Segmentation:
Monoclonal antibody therapy market has been segmented on the basis of source which comprises of recombinant, chimeric, humanized, human, and other. On the basis of application, market is segmented into diagnostic test, analytical and chemical uses, cancer treatment, autoimmune diseases, hematological disorders, and others. On the basis of end user, market is segmented into hospitals, clinic, research laboratories and others.
Table Of Content:
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5 GLOBAL MONOCLONAL ANTIBODY THERAPY MARKET, BY SOURCE
Continue....
Browse Complete Report @ https://www.marketresearchfuture.com/reports/monoclonal-antibody-th...
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation